瑞密斯醫(yī)藥是匈牙利吉瑞大藥廠與瑞密斯醫(yī)藥共同在華成立的、由匈牙利吉瑞大藥廠持有多數(shù)股權(quán)的合資企業(yè)。合資企業(yè)設(shè)立后，瑞密斯/吉瑞密斯將進(jìn)一步推動匈牙利吉瑞大藥廠處方藥和非處方藥產(chǎn)品在中國市場的銷售，并致力于引進(jìn)第三方產(chǎn)品。2013年，瑞密斯/吉瑞密斯實際員工數(shù)已達(dá)300名，實現(xiàn)銷售額達(dá)4億人民幣。在中國，瑞密斯是僅有幾家擁有自身銷售團隊及品牌銷售權(quán)，且能同時為處方藥和非處方藥產(chǎn)品提供綜合性服務(wù)的企業(yè)之一。作為一家全新的、職能一體化的醫(yī)藥公司，瑞密斯遵照跨國企業(yè)運營標(biāo)準(zhǔn)，為您的產(chǎn)品在中國市場的成功銷售提供所有必需的綜合性服務(wù)。
更多信息請瀏覽企業(yè)網(wǎng)址：www.rxmidas.com

Rxmidas is a majority stake JV of Gedeon Richter with Rxmidas Pharmaceuticals in China. Rxmidas/GRmidas will further boost the expansion of Gedeon Richter’s Rx and OTC products and licensed-in third party products in China. Rxmidas/GRmidas achieved sales of 55 mio USD in 2012 with a staff of 270. Rxmidas/GRmidas is one of the only service providers in China who can cover both the Rx and OTC market with their own sales-force and integrated services under the Rxmidas and GRmidas brand franchises. Rxmidas/GRmidas is a new breed of service provider being a fully integrated pharmaceutical company, operating according to multinational standards and offering in house all services necessary for your products to be successful in China.
Please visit the enterprise website to get more information: www.rxmidas.com